Saudi Pharmaceutical Industries and Medical Appliances Corporation

2070.SRSAUHealthcare● Active

$28.50

$-0.40(-1.38%)

Market Cap$3.4B

P/E Ratio—

52W High$33.12

52W Low$22

Avg Volume639K

Open$29.00

Beta0.40

Overview

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

2070.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

2070.SR · FCF · TTM · margin & CAGR

Free cash flow was $183.2M for FY2025 (fiscal year ending 2025-12-31), up 146.0% year-over-year The FCF margin was 10.7%.

FY2025 Free Cash Flow$183.2M▲ +146.0% YoY

Trailing 12M (TTM)$281.1Mtrailing 4 quarters sum

FCF Margin10.7%$183.2M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

2070.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$272.4M(89M)$183.2M▲ +146.0%10.7%

FY2024−$331.0M(67M)−$398.0M▼ 471.7%-23.7%

FY2023$47.7M(117M)−$69.6M▲ +66.7%-4.2%

FY2022−$124.2M(85M)−$208.8M▼ 7468.5%-14.6%

FY2021$86.7M(84M)$2.8M▲ +101.6%0.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

2070.SR · P/FCF · FCF yield · FCF per share

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) trades at a FCF yield of 8.26% and a price-to-free-cash-flow ratio of 12.1x. FCF per share stands at $2.35, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

8.26%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$2.35

TTM FCF ÷ Shares Outstanding

Price / FCF

x12.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x16.1

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

2070.SR · cash flow statement · operating / investing / financing

For FY2025, Saudi Pharmaceutical Industries and Medical Appliances Corporation generated $272.4M in operating cash flow and spent 89M in capital expenditures, yielding $183.2M in free cash flow.

Operating Activities

+$272.4M

Cash from core business operations

2025-12-31

Investing Activities

−$85.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$103.9M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($272.4M) − |CapEx| (89M) = FCF ($183.2M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

2070.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Saudi Pharmaceutical Industries and Medical Appliances CorporationYOU

2070.SR

$183.2M+146.0%10.7%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) reported free cash flow of $183.2M for FY2025 (fiscal year ending 2025-12-31), up 146.0% year-over-year. The FCF margin was 10.7%.

Based on available data, Saudi Pharmaceutical Industries and Medical Appliances Corporation has maintained positive free cash flow for at least 6 fiscal year(s). FCF peaked at $183.2M in FY2025.

Saudi Pharmaceutical Industries and Medical Appliances Corporation's FCF yield is 8.26% and price-to-FCF ratio is 12.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

2070.SR free cash flow · 8 questions

Saudi Pharmaceutical Industries and Medical Appliances Corporation free cash flow was $183.2M for FY2025, up 146.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $281.1M.

2070.SR free cash flow2070.SR FCF2070.SR FCF 20252070.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Saudi Pharmaceutical Industries and Medical Appliances Corporation · Saudi Pharmaceutical Industries and Medical Appliances Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026